Goldman Sachs Group Inc Novavax Inc Transaction History

Goldman Sachs Group Inc

$605 Billion
Q3 2024

A detailed history of Goldman Sachs Group Inc transactions in Novavax Inc stock. As of the latest transaction made, Goldman Sachs Group Inc holds 909,734 shares of NVAX stock, worth $7.91 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

909,734

Previous 1,431,157 36.43%

Holding current value

$7.91 Million

Previous $18.1 Million 36.59%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$10.71 - $17.11 $5.58 Million - $8.92 Million	-521,423 Reduced 36.43%	909,734 $11.5 Million
Q2 2024 Aug 13, 2024	BUY	$3.89 - $20.97 $1.92 Million - $10.4 Million	494,662 Added 52.82%	1,431,157 $18.1 Million
Q1 2024 May 15, 2024	BUY	$3.76 - $6.02 $273,581 - $438,021	72,761 Added 8.42%	936,495 $4.48 Million
Q4 2023 Feb 13, 2024	BUY	$4.8 - $7.67 $1.43 Million - $2.28 Million	297,887 Added 52.64%	863,734 $4.15 Million
Q3 2023 May 14, 2024	SELL	$6.81 - $9.74 $2.03 Million - $2.9 Million	-297,887 Reduced 34.49%	565,847 $4.1 Million
Q3 2023 Nov 14, 2023	BUY	$6.81 - $9.74 $197,190 - $282,031	28,956 Added 5.39%	565,847 $4.1 Million
Q2 2023 May 14, 2024	SELL	$6.67 - $9.52 $3.29 Million - $4.7 Million	-493,950 Reduced 47.92%	536,891 $3.99 Million
Q2 2023 Aug 14, 2023	SELL	$6.67 - $9.52 $3.29 Million - $4.7 Million	-493,950 Reduced 47.92%	536,891 $3.99 Million
Q1 2023 May 14, 2024	SELL	$5.76 - $12.48 $1.69 Million - $3.66 Million	-293,010 Reduced 22.13%	1,030,841 $7.14 Million
Q1 2023 May 11, 2023	SELL	$5.76 - $12.48 $1.69 Million - $3.66 Million	-293,010 Reduced 22.13%	1,030,841 $7.14 Million
Q4 2022 May 14, 2024	BUY	$8.86 - $25.04 $3.21 Million - $9.07 Million	362,393 Added 37.69%	1,323,851 $13.6 Million
Q4 2022 Feb 13, 2023	BUY	$8.86 - $25.04 $3.21 Million - $9.07 Million	362,393 Added 37.69%	1,323,851 $13.6 Million
Q3 2022 May 14, 2024	BUY	$18.2 - $76.12 $6.3 Million - $26.4 Million	346,261 Added 56.28%	961,458 $17.5 Million
Q3 2022 Nov 10, 2022	BUY	$18.2 - $76.12 $6.3 Million - $26.4 Million	346,261 Added 56.28%	961,458 $17.5 Million
Q2 2022 May 14, 2024	SELL	$36.28 - $75.29 $9.02 Million - $18.7 Million	-248,537 Reduced 28.77%	615,197 $31.6 Million
Q2 2022 Aug 15, 2022	BUY	$36.28 - $75.29 $4.59 Million - $9.52 Million	126,453 Added 25.87%	615,197 $31.6 Million
Q1 2022 May 16, 2022	BUY	$69.73 - $142.9 $9.21 Million - $18.9 Million	132,144 Added 37.06%	488,744 $36 Million
Q4 2021 Feb 14, 2022	SELL	$134.56 - $217.97 $2.67 Million - $4.32 Million	-19,812 Reduced 5.26%	356,600 $51 Million
Q3 2021 Nov 10, 2021	BUY	$177.8 - $270.58 $66.9 Million - $102 Million	376,412 New	376,412 $78 Million

Others Institutions Holding NVAX

# of Institutions

290

Shares Held

93.4M

Call Options Held

6.95M

Put Options Held

9.4M

View Full List

About NOVAVAX INC

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $680M
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

More about NVAX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Account

Goldman Sachs Group Inc Novavax Inc Transaction History